[go: up one dir, main page]

DE60103854D1 - Zusammensetzung zur vorbeugung und/oder behandlung von lipidstoffwechselstörungen und allergischen formen - Google Patents

Zusammensetzung zur vorbeugung und/oder behandlung von lipidstoffwechselstörungen und allergischen formen

Info

Publication number
DE60103854D1
DE60103854D1 DE60103854T DE60103854T DE60103854D1 DE 60103854 D1 DE60103854 D1 DE 60103854D1 DE 60103854 T DE60103854 T DE 60103854T DE 60103854 T DE60103854 T DE 60103854T DE 60103854 D1 DE60103854 D1 DE 60103854D1
Authority
DE
Germany
Prior art keywords
prevention
treatment
composition
metabolic disorders
lipid metabolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60103854T
Other languages
English (en)
Other versions
DE60103854T2 (de
Inventor
Pietro Pola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE60103854D1 publication Critical patent/DE60103854D1/de
Publication of DE60103854T2 publication Critical patent/DE60103854T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60103854T 2000-11-17 2001-07-24 Zusammensetzung zur vorbeugung und/oder behandlung von lipidstoffwechselstörungen und allergischen formen Expired - Fee Related DE60103854T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2000RM000602A IT1317938B1 (it) 2000-11-17 2000-11-17 Composizione per la prevenzione e/o il trattamento di alterazioni delmetabolismo lipidico, delle forme allergiche e per attivare le difese
ITRM20000602 2000-11-17
PCT/IT2001/000394 WO2002040012A1 (en) 2000-11-17 2001-07-24 Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms

Publications (2)

Publication Number Publication Date
DE60103854D1 true DE60103854D1 (de) 2004-07-22
DE60103854T2 DE60103854T2 (de) 2005-07-14

Family

ID=11455002

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60103854T Expired - Fee Related DE60103854T2 (de) 2000-11-17 2001-07-24 Zusammensetzung zur vorbeugung und/oder behandlung von lipidstoffwechselstörungen und allergischen formen

Country Status (19)

Country Link
US (1) US7211571B2 (de)
EP (1) EP1257267B1 (de)
AT (1) ATE269073T1 (de)
AU (1) AU778952B2 (de)
CA (1) CA2406925A1 (de)
CZ (1) CZ20022307A3 (de)
DE (1) DE60103854T2 (de)
DK (1) DK1257267T3 (de)
ES (1) ES2222388T3 (de)
HU (1) HUP0204209A3 (de)
IL (1) IL150637A0 (de)
IT (1) IT1317938B1 (de)
MX (1) MXPA02007001A (de)
NO (1) NO20023117D0 (de)
PL (1) PL355200A1 (de)
PT (1) PT1257267E (de)
SK (1) SK10282002A3 (de)
TR (1) TR200401572T4 (de)
WO (1) WO2002040012A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
SG10201402287TA (en) 2009-05-11 2014-07-30 Berg Llc Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
KR101933732B1 (ko) 2011-04-04 2018-12-28 버그 엘엘씨 중추 신경 시스템 종양들의 치료 방법
WO2014168993A1 (en) 2013-04-08 2014-10-16 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
ES2825083T3 (es) 2013-09-04 2021-05-14 Berg Llc Métodos de tratamiento contra el cáncer mediante infusión continua de coenzima Q10
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975421A (en) * 1985-08-19 1990-12-04 Bioglucan, Lp. Soluble phosphorylated glucan: methods and compositions for wound healing
US5977073A (en) * 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
IT1277897B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso della l-carnitina,di suoi derivati e di loro sali farmaceuticamen- te accettabili in combinazione con farmaci antiretrovirali per ridurre
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1290801B1 (it) * 1996-07-05 1998-12-11 Mendes Srl Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
SI0951909T2 (sl) 1998-03-19 2010-11-30 Sigma Tau Ind Farmaceuti Kombinirana zmes ki vsebuje L karnitin ali alkanoil L karnitin glikozaminoglikan in ali njegov sestavni del
AU2437101A (en) * 1999-12-16 2001-06-25 Harry Siskind Nutritional composition, methods of producing said composition and methods of using said composition

Also Published As

Publication number Publication date
CA2406925A1 (en) 2002-05-23
ITRM20000602A1 (it) 2002-05-17
EP1257267A1 (de) 2002-11-20
PL355200A1 (en) 2004-04-05
AU7667501A (en) 2002-05-27
IT1317938B1 (it) 2003-07-15
DE60103854T2 (de) 2005-07-14
WO2002040012A1 (en) 2002-05-23
TR200401572T4 (tr) 2004-09-21
ES2222388T3 (es) 2005-02-01
US7211571B2 (en) 2007-05-01
NO20023117L (no) 2002-06-27
US20030017999A1 (en) 2003-01-23
PT1257267E (pt) 2004-09-30
ATE269073T1 (de) 2004-07-15
CZ20022307A3 (cs) 2003-01-15
NO20023117D0 (no) 2002-06-27
HUP0204209A2 (hu) 2003-04-28
AU778952B2 (en) 2004-12-23
ITRM20000602A0 (it) 2000-11-17
IL150637A0 (en) 2003-02-12
MXPA02007001A (es) 2003-01-28
HUP0204209A3 (en) 2005-03-29
DK1257267T3 (da) 2004-10-25
SK10282002A3 (sk) 2003-03-04
EP1257267B1 (de) 2004-06-16

Similar Documents

Publication Publication Date Title
DE602004009295D1 (de) 1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
BRPI0519265A2 (pt) composiÇÕes incluindo ferro
CA2529735A1 (en) Eicosapentaenoic acid for preventing or treating varicose veins of lower extremities
ATE429156T1 (de) Nahrungsergänzung zur behandlung von makula degeneration
ATE428699T1 (de) Pyrazolylderivative in form von arzneimitteln zur behandlung von akuten oder chronischen neuronalen regressionen
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
MX2009003202A (es) Tratamiento de jugos, extractos y pigmentos de plantas.
HUP0300732A2 (hu) Chlamydiás fertżzések kezelésében és megelżzésében hatékony növényi-eredetż és szintetikus fenolos vegyületek és növényi extraktumok
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
ATE516809T1 (de) Pflanzen der gattung ampelopsis und deren extrakte zur behandlung von schlafstörungen
ATE269073T1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von lipidstoffwechselstörungen und allergischen formen
TW200508210A (en) Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
ATE397453T1 (de) Zusammensetzung zur behandlung und/oder vorbeugung von insulinresistenz
FR2842422B1 (fr) Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations
CN103937599A (zh) 一种抗氧化保健花生油及其制备工艺
BRPI0516996A (pt) produto aliementìcio contendo um ou vários microorganismos vivos e pelo menos um ingrediente aliementìcio bioativo de interesse, processo de encapsulação de pelo menos um ingrediente alimentìcio bioativo de interesse em uma matéria graxa, e, utilizações de um produto alimentìcio e de uma matéria graxa
ITFI20030194A1 (it) Composizione farmaceutiche effervescenti contenenti
ATE239504T1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von störungen aufgrund von abnormalen fettstoffmetabolismus, enthaltend l-carnitin und chitosan
DE602004027923D1 (de) Zusammensetzung mit notoginseng radix extrakt zur prävention und behandlung von arthritis als wirksamer inhaltsstoff
HK1221598A2 (zh) 口服药物组合物以及治疗或预防疾病的方法
PL367613A1 (en) Composition for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
WO2006134135A3 (en) Nutritional method for elderly people
ATE335473T1 (de) Zusammensetzung zur verhinderung und/oder behandlung von gefässerkrankungen, bestehend aus propionyl-l-carnitin und coenzym q10
DE602006021594D1 (de) Verbindung zur prävention und behandlung von links

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee